Researchers report Alzheimer's disease and other neurodegenerative disorders can be confirmed in living patients by specific biomarkers in cerebrospinal fluid.
Ceramide exposure impairs the ability for neurons to make energy by directly damaging mitochondria. Additionally, ceramides force neurons to rapidly uptake glucose in order to provide cellular energy.
Researchers have discovered a new biomarker that can help diagnose Huntington's disease. They note the findings could result in the development of treatments to postpone neuron death in those who carry the Huntington's gene mutation, but who do not currently show symptoms of the disease.
Researchers have devised a new blood test that can detect if amyloid had begun to accumulate in the brain. The test help physicians diagnose Alzheimer's disease in a cheaper, less invasive way than currently available. The researchers will present their findings at the Alzheimer's Association International Conference in London.
Researchers say their findings about immune system changes early in Alzheimer's could lead to new blood tests that may be used to detect the disease before it becomes symptomatic.
Study reports elevated amyloid plaque are not just a risk factor for Alzheimer's, but part of the disease and the earliest precursor before symptoms appear.
A new study reports on a surprising link between OSA and Alzheimer's disease. Researchers report people who suffer a number of apneas per hour have increased accumulation of amyloid beta in the brain over time.
Boston University School of Medicine researchers have identified several new genes associated with Alzheimer's disease, including some which may cause functional and structural alterations in the brain. The findings could help to shed light on the processes leading up to the development of the neurodegenerative disease.
According to researchers, pediatric leukemia patients exposed to high levels of methotrexate are more likely to have problems with mental flexibility and other cognitive skills as long term survivors.
Children diagnosed with autism at the age of two had substantially greater amounts of extra axial cerebrospinal fluid at 6 and 12 months. Additionally, the level of increased CSF at 6 months could be correlated with the severity of autism symptoms displayed at 2 years, a new study reports.
Findings shed light on the mechanisms underlying brain damage in microgravity.
Study reveals changes in blood flow to different brain areas may be the earliest sign of Alzheimer's disease.